INFLUENCE OF CYP2B6*6 GENOTYPE ON BUPROPION ENANTIOMERS METABOLISM AND CLEARANCE

被引：0
|
作者：
Kharasch, E. D. [1 ]
Crafford, A. [1 ]
Parchomski, J. [1 ]
Blood, J. [1 ]
Regina, K. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [41] Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for CYP2B6 activity.
    Kharasch, E. D.
    Mitchell, D.
    Coles, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S35 - S35
  • [42] Effect of kidney disease on the hepatic CYP2B6 activity as measured by bupropion pharmacokinetics
    Miia, Turpeinen
    Niina, Koivuviita
    Ari, Tolonen
    Petri, Reponen
    Stefan, Lundgren
    Jouko, Miettunen
    Kaj, Metsarinne
    Anders, Rane
    Olavi, Pelkonen
    Kari, Laine
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 203 - 203
  • [43] The CYP2B6*6 Allele Significantly Alters the N-Demethylation of Ketamine Enantiomers In Vitro
    Li, Yibai
    Coller, Janet K.
    Hutchinson, Mark R.
    Klein, Kathrin
    Zanger, Ulrich M.
    Stanley, Nathan J.
    Abell, Andrew D.
    Somogyi, Andrew A.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (06) : 1264 - 1272
  • [44] Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients
    Nazan Yuce-Artun
    Bora Baskak
    Erguvan Tugba Ozel-Kizil
    Hatice Ozdemir
    Zuhal Uckun
    Halise Devrimci-Ozguven
    Halit Sinan Suzen
    International Journal of Clinical Pharmacy, 2016, 38 : 388 - 394
  • [45] PharmVar GeneFocus: CYP2B6
    Desta, Zeruesenay
    El-Boraie, Ahmed
    Gong, Li
    Somogyi, Andrew A.
    Lauschke, Volker M.
    Dandara, Collet
    Klein, Kathrin
    Miller, Neil A.
    Klein, Teri E.
    Tyndale, Rachel F.
    Whirl-Carrillo, Michelle
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 82 - 97
  • [46] Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population
    Masahiro Hiratsuka
    Yoh Takekuma
    Naomi Endo
    Kaori Narahara
    Samar Hamdy
    Yukinaga Kishikawa
    Masaki Matsuura
    Yasuyuki Agatsuma
    Tomoko Inoue
    Michinao Mizugaki
    European Journal of Clinical Pharmacology, 2002, 58 : 417 - 421
  • [47] Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients
    Yuce-Artun, Nazan
    Baskak, Bora
    Ozel-Kizil, Erguvan Tugba
    Ozdemir, Hatice
    Uckun, Zuhal
    Devrimci-Ozguven, Halise
    Suzen, Halit Sinan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 388 - 394
  • [48] CYP2B6 and POR Polymorphisms Influence Metabolism and Clinical Outcomes of Perioperative Methadone in Children
    Packiasabapathy, Senthil
    Aruldhas, Blessed
    Zhang, Pengyue
    Sadhasivam, Senthilkumar
    ANESTHESIA AND ANALGESIA, 2021, 132 (5S_SUPPL): : 791 - 793
  • [49] Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population
    Hiratsuka, M
    Takekuma, Y
    Endo, N
    Narahara, K
    Hamdy, SI
    Kishikawa, Y
    Matsuura, M
    Agatsuma, Y
    Inoue, T
    Mizugaki, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) : 417 - 421
  • [50] Stereoselective metabolism of methadone (M) by CYP2B6 and CYP2C19.
    Gerber, JG
    Rhodes, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P11 - P11
12345